Introduction. Improving the standard of care in the management of cancer-related anaemia: focus on darbepoetin alfa, a novel erythropoiesis-stimulating protein.
Glaspy
J
J
UCLA School of Medicine, 200 Medical Plaza, Suite 120, Los Angeles, CA, 90024 USA.
D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D002986:Clinical Trials as Topic; D000068256:Darbepoetin alfa; D004353:Drug Evaluation, Preclinical; D004921:Erythropoietin / Q000031:analogs & derivatives / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006207:Half-Life; D006801:Humans; D009369:Neoplasms / Q000097:blood / Q000150:complications*; D011994:Recombinant Proteins / Q000493:pharmacokinetics / Q000627:therapeutic use
D011994:Recombinant Proteins; D004921:Erythropoietin; D000068256:Darbepoetin alfa